Mike Crapo actually said...

I have long championed efforts to improve prescription drug access and affordability for Americans, and I welcome the opportunity to engage ...

Obviously, transparency is key.

That said, much has changed in the past 2 decades, and we have an obligation both to build on the aspects of Part D that work well and to ad...

NACDS appreciates the Committee's work to explore PBMs' lack of transparency and standardized performance measures.